Masimo | MASI - Debt


Masimo reported $485.9M in Debt for its fiscal quarter ending in March of 2026.





Debt Change Date
Abbott USD 13.86B 919M Dec/2025
Accuray USD 170.24M 4.52M Sep/2024
Align Technology USD 114.45M 6.82M Dec/2025
AngioDynamics USD 6.3M 6.3M Feb/2025
Artivion USD 317.78M 619K Dec/2024
AtriCure USD 73.38M 3.35M Dec/2025
Avanos Medical USD 129.1M 4.6M Dec/2025
Baxter International USD 9.78B 68M Dec/2025
Becton, Dickinson and Co. USD 19.54B 358M Dec/2025
Boston Scientific USD 11.44B 610M Dec/2025
Dexcom USD 1.24B 900K Mar/2026
Edwards Lifesciences USD 600M 105.4M Mar/2026
General Electric Aerospace USD 20.28B 217M Mar/2026
Globus Medical USD 118.66M 687K Dec/2025
Haemonetics USD 1.22B 5K Dec/2025
Inogen USD 0 0 Jun/2022
Insulet USD 949.2M 65.6M Dec/2025
Integra LifeSciences USD 2.04B 6.27M Mar/2026
Intuitive Surgical USD 0 0 Mar/2025
Masimo USD 485.9M 100.3M Mar/2026
Medtronic USD 28.07B 1.03B Dec/2025
Orthofix International USD 137.23M 338K Sep/2024
Owens Minor USD 1.95B 91.18M Mar/2025
ResMed USD 847.72M 1.37M Dec/2025
Steris USD 2.05B 4.8M Dec/2025
Stryker USD 14.22B 635M Mar/2026
Tandem Diabetes Care USD 444.48M 4.81M Dec/2025
Teleflex USD 2.73B 43.5M Dec/2025
Thermo Fisher Scientific USD 39.39B 3.7B Dec/2025
Zimmer Biomet Holdings USD 7.47B 48.1M Mar/2026